Stocks and Investing
Stocks and Investing
Fri, January 5, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Thu, January 4, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
David Hoang Initiated (XENE) at Strong Buy and Held Target at $62 on, Jan 4th, 2024
David Hoang of Citigroup, Initiated "Xenon Pharmaceuticals Inc." (XENE) at Strong Buy and Held Target at $62 on, Jan 4th, 2024.
David has made no other calls on XENE in the last 4 months.
There are 6 other peers that have a rating on XENE. Out of the 6 peers that are also analyzing XENE, 0 agree with David's Rating of Hold.
These are the ratings of the 6 analyists that currently disagree with David
- Jason Gerberry of "B of A Securities" Maintained at Strong Buy with Increased Target to $56 on, Tuesday, January 2nd, 2024
- Stephen Willey of "Stifel" Maintained at Strong Buy with Increased Target to $62 on, Monday, December 18th, 2023
- Brian Skorney of "Baird" Initiated at Buy and Held Target at $63 on, Friday, December 8th, 2023
- Brian Abrahams of "RBC Capital" Maintained at Buy with Increased Target to $56 on, Tuesday, November 28th, 2023
- Laura Chico of "Wedbush" Maintained at Buy with Decreased Target to $46 on, Thursday, November 9th, 2023
- Josh Schimmer of "Cantor Fitzgerald" Initiated at Buy on, Tuesday, October 24th, 2023
Contributing Sources